Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)
Status:
Completed
Trial end date:
2008-08-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if esmirtazapine (Org 50081) is a safe and
effective treatment for insomnia. It was anticipated that esmirtazapine would increase mean
Total Sleep Time (TST) as recorded in sleep diaries relative to placebo.